MedPath

AK-131

Generic Name
AK-131

A Study of AK131 in Patients With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2023-12-12
Last Posted Date
2024-01-17
Lead Sponsor
Akeso
Target Recruit Count
130
Registration Number
NCT06166888
Locations
🇨🇳

Jinming Yu, Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath